Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences
RICHMOND, Calif., March 5, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Dr. Sandy Macrae, CEO of Sangamo, is scheduled to participate in the following healthcare investor conferences in March.
Cowen 38th Annual Health Care Conference, Boston, MA, March 12-14, 2018
Dr. Macrae is scheduled to present at 1:30 p.m. ET on Monday, March 12th.
Barclays 2018 Global Healthcare Conference, Miami, FL, March 13-15, 2018
Dr. Macrae is scheduled to present at 10:15 a.m. ET on Thursday, March 15th.
The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentations-at-upcoming-investor-conferences-300608274.html
SOURCE Sangamo Therapeutics, Inc.
Released March 5, 2018